Corporate Ozempic | Why losing staff may make you leaner but not fitter

 Why losing staff may make you leaner but not fitter

The recent wave of layoffs sweeping through the US job market, especially in the tech sector, might be viewed by business leaders as a dose of corporate Ozempic, creating leaner, more efficient, organizations but, like any wonder drug, it may come with serious side effects.

There are significant questions about the long-term impact on employee engagement among those who remain with the company, according to continued research from the Harvard Business Review (HBR).

Continue reading for FREE!

Sign up for a myGrapevine account to get:

  • Unlimited access to News content
  • The latest Features, Columns & Opinions
  • A full range of specialist HR newsletters to choose from

Welcome Back

* By creating an account you agree that you have read and agree to our Terms and Conditions and that Executive Grapevine International Ltd and its partners may contact you regarding relevant content and products. You will also be added to the HR Grapevine newsletter mailing list.